Personalized Physical Back Training Program to Improve Physical Functioning in People With Non-specific Low Back Pain

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorClaudio Perret

About this trial

Personalized medicine and individualized therapeutic approaches are prominent in current research. But are these approaches also effective for treating non-specific low back pain (NSLBP)? NSLBP is one of the most common musculoskeletal issues, which can impair physical well-being, reduce the quality of life, and limit physical functioning. Additionally, it contributes to substantial direct and indirect healthcare costs, such as frequent doctor visits and work absences. Despite NSLBP being a significant burden for both individuals and society, effective alleviation methods remain unclear. The investigators' research project therefore aims to investigate whether personalized therapy, specifically a personalized physical back training program, can effectively address NSLBP. Within the context of NSLBP, the investigators' specific aim is to improve physical functioning as this outcome is considered relevant from all perspectives, including those of patients, clinical professionals, researchers, and guidelines.

Eligibility criteria

Qualifiers

Access to the University Sports of the Lucerne Universities (i.e., students, employees, alumni, subscribers)

NSLBP for at least 6 weeks

Activity limiting NSLBP (at least one activity with a PSFS Score of ≤ 50/100 on a scale from 0 = unable to perform due to NSLBP to 100 = able to perform at the same level as before NSLBP)

Age between 18 and 65 years

Disqualifiers

Specific LBP

Red flags associated with any serious pathology or specific LBP,

Being on a waiting list for or less than 12 months post any surgery of the lower back

Pregnancy or given birth within the last 12 months

Trial design

Treatments tested in this trial

  • Personalized back exercises
  • Non-personalized back exercises

Treatment groups

180 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Claudio Perret

Lead sponsor

Universität Luzern

Sponsor institution